ACB
Price
$4.84
Change
+$0.03 (+0.62%)
Updated
Jul 25 closing price
Capitalization
238.86M
10 days until earnings call
SCYX
Price
$0.74
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
55.88M
22 days until earnings call
Interact to see
Advertisement

ACB vs SCYX

Header iconACB vs SCYX Comparison
Open Charts ACB vs SCYXBanner chart's image
Aurora Cannabis
Price$4.84
Change+$0.03 (+0.62%)
Volume$721.18K
Capitalization238.86M
SCYNEXIS
Price$0.74
Change-$0.00 (-0.00%)
Volume$314
Capitalization55.88M
ACB vs SCYX Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. SCYX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and SCYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ACB: $4.84 vs. SCYX: $0.74)
Brand notoriety: ACB: Notable vs. SCYX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 58% vs. SCYX: 0%
Market capitalization -- ACB: $238.86M vs. SCYX: $55.88M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. SCYX’s [@Pharmaceuticals: Other] market capitalization is $55.88M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileSCYX’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • SCYX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish while SCYX’s TA Score has 5 bullish TA indicator(s).

  • ACB’s TA Score: 4 bullish, 5 bearish.
  • SCYX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SCYX is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +6.84% price change this week, while SCYX (@Pharmaceuticals: Other) price change was +1.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

ACB is expected to report earnings on Aug 06, 2025.

SCYX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than SCYX($55.9M). ACB YTD gains are higher at: 13.882 vs. SCYX (-39.008). SCYX has higher annual earnings (EBITDA): 70.9M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. SCYX (74.4M). SCYX has less debt than ACB: SCYX (15.1M) vs ACB (103M). ACB has higher revenues than SCYX: ACB (212M) vs SCYX (140M).
ACBSCYXACB / SCYX
Capitalization239M55.9M428%
EBITDA-1.64B70.9M-2,309%
Gain YTD13.882-39.008-36%
P/E RatioN/A1.06-
Revenue212M140M151%
Total Cash149M74.4M200%
Total Debt103M15.1M682%
FUNDAMENTALS RATINGS
ACB vs SCYX: Fundamental Ratings
ACB
SCYX
OUTLOOK RATING
1..100
8611
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8997
PRICE GROWTH RATING
1..100
4689
P/E GROWTH RATING
1..100
8298
SEASONALITY SCORE
1..100
5011

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCYX's Valuation (53) in the Pharmaceuticals Other industry is in the same range as ACB (55). This means that SCYX’s stock grew similarly to ACB’s over the last 12 months.

SCYX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ACB (100). This means that SCYX’s stock grew similarly to ACB’s over the last 12 months.

ACB's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as SCYX (97). This means that ACB’s stock grew similarly to SCYX’s over the last 12 months.

ACB's Price Growth Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for SCYX (89). This means that ACB’s stock grew somewhat faster than SCYX’s over the last 12 months.

ACB's P/E Growth Rating (82) in the Pharmaceuticals Other industry is in the same range as SCYX (98). This means that ACB’s stock grew similarly to SCYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBSCYX
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 7 days ago
50%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANUY15.070.16
+1.07%
Fanuc Corporation
ICGUF27.50N/A
N/A
Intermediate Capital Group Plc.
CRPHY0.67N/A
N/A
Ceres Power Holdings plc
SLVTF0.43N/A
-1.00%
Silver Tiger Metals Inc.
EMAUF0.20-0.01
-3.10%
EMPEROR METALS INC.

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with CGC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+0.62%
CGC - ACB
64%
Loosely correlated
+2.70%
OGI - ACB
60%
Loosely correlated
+1.32%
CRON - ACB
56%
Loosely correlated
-0.97%
TLRY - ACB
54%
Loosely correlated
-2.03%
CRDL - ACB
36%
Loosely correlated
+2.86%
More

SCYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCYX has been loosely correlated with CRDL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SCYX jumps, then CRDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
N/A
CRDL - SCYX
34%
Loosely correlated
+2.86%
AQST - SCYX
31%
Poorly correlated
-1.19%
AKAN - SCYX
29%
Poorly correlated
+0.79%
TLRY - SCYX
28%
Poorly correlated
-2.03%
ACB - SCYX
26%
Poorly correlated
+0.62%
More